Biden eyes bigger US role in global vaccination efforts

The Biden administration is taking initial steps toward an expanded role in global COVID-19 vaccination efforts, while stopping short of sharing excess doses on a wide scale.

The federal government has been amassing doses, growing its supply into what will likely become a surplus as the rest of the world struggles with shortages.

In fact, the U.S. has purchased enough vaccines to immunize every adult in the country three times over. Aid groups now say it's past time to start giving away the surplus.


The administration, however, remains hesitant to do so.

The U.S. vaccination campaign has been relatively successful to date, averaging close to 3 million shots administered every day. About a quarter of all adults have been fully vaccinated, and the Biden administration is well on its way to achieving its goal of inoculating 200 million people by the end of April.

But most of the U.S. international support has come in the form of money, with the administration committing $4 billion to the World Health organization-backed COVAX vaccine initiative.

The U.S. is also co-hosting a fundraising campaign for COVAX in the coming days, with the aim of calling on wealthy nations to join the United States and others in providing resources and commitments to accelerate global COVID-19 vaccinations.

In recent days, top financial and diplomatic officials have indicated they are thinking about next steps, and how to balance the humanitarian needs and possible political implications of vaccine diplomacy.

Secretary of State Antony BlinkenAntony BlinkenUS says 'swift' return to Iran deal possible ahead of Vienna talks Blinken: US stands with Ukraine in face of Russian aggression The Hill's Morning Report - Presented by Emergent BioSolutions - Facebook upholds Trump ban; GOP leaders back Stefanik to replace Cheney MORE on Monday said he has been hearing the calls to share doses.


"I know that many countries are asking for the United States to do more, some with growing desperation because of the scope and scale of their COVID emergencies. We hear you. And I promise, we’re moving as fast as possible," Blinken said.

In response to those calls, he announced the appointment of Gayle Smith as U.S. coordinator for global COVID-19 response and health security.

Smith most recently served as president and CEO of the ONE Campaign, a nonpartisan organization that advocates for ending poverty and preventable disease by 2030.

The ONE Campaign has been pressuring the administration to ship some of its vaccine supply to developing countries.

Late last month, the group joined a coalition of 30 nongovernmental organizations in sending a letter to Biden, urging him to immediately begin to develop a plan to share excess vaccine doses.

“It is estimated that there could be twice as many deaths from COVID-19 if rich countries monopolize the first doses of vaccines instead of making sure they are distributed globally,” the groups wrote.

The hope for advocates is that Smith, who helped lead the Obama administration’s response to the Ebola outbreak in 2014, will play a pivotal role in designing such a program.

In a dig at Russia and China, which have been more than willing to donate vaccines as a way to foster friendly relations, Blinken noted that when the time comes for the U.S. to send doses overseas, the nation "won’t trade shots in arms for political favors. This is about saving lives."

Treasury Secretary Janet YellenJanet Louise YellenWaPo reporter: Treasury continuing recovery plan amid complaints of labor shortage, inflation Business groups target moderate Democrats on Biden tax plans On The Money: How demand is outstripping supply and hampering recovery | Montana pulls back jobless benefits | Yellen says higher rates may be necessary MORE recently spoke about the role wealthy countries need to play in helping to end the pandemic.

During a speech before the Chicago Council on Global Affairs, Yellen warned that the economic toll of the pandemic will push 150 million people into extreme poverty this year without a substantial increase in support for developing countries.

“Our first task must clearly be stopping the virus by ensuring that vaccinations, testing and therapeutics are available as widely as possible," she said.

President BidenJoe BidenAtlanta mayor won't run for reelection South Carolina governor to end pandemic unemployment benefits in June Airplane pollution set to soar with post-pandemic travel boom MORE has so far only committed to providing about 4 million doses of AstraZeneca's vaccine, which is not yet authorized in the U.S., to Mexico and Canada.


"The president remains committed to playing a constructive role in the global effort to defeat the virus," White House press secretary Jen PsakiJen PsakiBriahna Joy Gray: Biden campaign promises will struggle if Republicans win back Congress The Hill's 12:30 Report - Presented by ExxonMobil - Trump moves to his own blog as Facebook ban remains in place Biden on Cheney drama: 'I don't understand the Republicans' MORE said Friday. "But as we've seen, this is an unpredictable virus and his first priority is ensuring the American people are vaccinated, and that means we need to plan for supply."

Psaki said the administration is planning for contingencies, and cited the recent error at a manufacturing plant producing the Johnson & Johnson vaccine that resulted in 15 million ruined doses. She also said the U.S. needs to plan for vaccinating children and the potential need for booster shots.

Tom Kenyon chief health officer at Project HOPE, a global health organization, said the appointment of Smith, and the remarks by Yellen and Blinken, is a sign the administration will eventually move to start sharing vaccines.

“But I think we have to move beyond the promise, to action," Kenyon said. "This is a pandemic, and it's an emergency."

Kenyon said the U.S. should have already been sending surplus supplies to help other countries protect their health workers.

"This is a public health endeavor, not a diplomatic endeavor alone. We need diplomacy, but we need public health action," Kenyon said.